Manulife (Manufacturers Life Insurance)
NAGE

Manulife (Manufacturers Life Insurance)’s Niagen Bioscience NAGE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.4K Sell
14,597
-1,810
-11% -$9.77K ﹤0.01% 2701
2025
Q4 		$104K Sell
16,407
-1,544
-9% -$10.7K ﹤0.01% 2694
2025
Q3 		$167K Sell
17,951
-1,485
-8% -$15K ﹤0.01% 2640
2025
Q2 		$280K Buy
19,436
+885
+5% +$8.74K ﹤0.01% 2412
2025
Q1 		$128K Buy
18,551
+1,010
+6% +$6.35K ﹤0.01% 2636
2024
Q4 		$93.1K Sell
17,541
-2,191
-11% -$12K ﹤0.01% 2834
2024
Q3 		$72K Buy
19,732
+8,485
+75% +$26.7K ﹤0.01% 2939
2024
Q2 		$30.7K Buy
+11,247
New +$37.6K ﹤0.01% 2948
2022
Q2 		– Sell
-11,279
Closed -$27.7K – 3165
2022
Q1 		$27.7K Sell
11,279
-15,098
-57% -$41.3K ﹤0.01% 3052
2021
Q4 		$99 Buy
26,377
+143
+0.5% +$772 ﹤0.01% 3054
2021
Q3 		$164K Sell
26,234
-909
-3% -$7.49K ﹤0.01% 3044
2021
Q2 		$268K Buy
27,143
+3,579
+15% +$31.2K ﹤0.01% 2896
2021
Q1 		$220K Sell
23,564
-3,809
-14% -$30.2K ﹤0.01% 2834
2020
Q4 		$131K Buy
27,373
+1,388
+5% +$6.77K ﹤0.01% 2903
2020
Q3 		$104K Hold
25,985
– – ﹤0.01% 2791
2020
Q2 		$118K Sell
25,985
-2,017
-7% -$9.03K ﹤0.01% 2699
2020
Q1 		$91K Buy
28,002
+1,803
+7% +$6.92K ﹤0.01% 2602
2019
Q4 		$113K Sell
26,199
-799
-3% -$2.84K ﹤0.01% 2769
2019
Q3 		$110K Hold
26,998
– – ﹤0.01% 2807
2019
Q2 		$126K Sell
26,998
-1,962
-7% -$8.37K ﹤0.01% 2838
2019
Q1 		$121K Buy
+28,960
New +$104K ﹤0.01% 2552

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NAGE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Niagen Bioscience (NAGE) stake by 11% in Q1 2026, selling an estimated $9.77K and leaving 14,597 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Manulife (Manufacturers Life Insurance) first reported a position in NAGE in Q1 2019 and has held it in 21 quarters since. The position peaked at $280K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 14,597 shares of Niagen Bioscience worth $64.4K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,810 Niagen Bioscience shares in Q1 2026, an estimated $9.77K.
  • Niagen Bioscience made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2701 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Niagen Bioscience in Q1 2019 and has held it in 21 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Niagen Bioscience position peaked at $280K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.